Spravato (Esketamine) is a prescribed intranasal antidepressant which is self-administered under the supervision of an Spravato (Esketamine) certified facility and physician. It is the latest innovation for Treatment Resistant Depression (TRD) and in adults with depressive symptoms and/or suicidal thoughts. In clinical trials many participants showed clinical improvement of depressive symptoms within 4 hours.
Most major insurance providers cover Spravato treatment, but an evaluation is required by Dr. Hendleman, in our St. George office, to first assess the suitability of treatment with each patient.
Spravato has the potential to dramatically lessen the symptoms in Treatment Resistant Depression and depression with suicidal thoughts. Schedule an appointment to discuss how Spravato could help you achieve Better Balance today!
